Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Guchelaar, H.J."'
Autor:
Hulshof, E.C., Lurvink, R.J., Caserta, N., de Hingh, I.H.J.T., van Wezel, T., Böhringer, S., Swen, J.J., Gelderblom, H., Guchelaar, H.J., Deenen, M.J.
Publikováno v:
In European Journal of Surgical Oncology October 2020 46(10) Part A:1925-1931
Autor:
Coppens, D.G.M. *, de Wilde, S. *, Guchelaar, H.J., De Bruin, M.L., Leufkens, H.G.M., Meij, P., Hoekman, J. *
Publikováno v:
In Cytotherapy June 2018 20(6):769-778
Publikováno v:
Cancer Chemotherapy and Pharmacology, 91(3), 257-266. SPRINGER
Purpose: Measurement of endogenous uracil (U) is increasingly being used as a dose-individualization method in the treatment of cancer patients with fluoropyrimidines. However, instability at room temperature (RT) and improper sample handling may cau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efdb0bca57f26cb8df055c3a2b4237ed
https://hdl.handle.net/1887/3594478
https://hdl.handle.net/1887/3594478
Autor:
Eektimmerman, F., Swen, J.J., Broeder, A.A. den, Hazes, J.M.W., Kurreeman, F.S., Verstappen, S.M.M., Nair, N., Pawlik, A., Nurmohamed, M.T., Dolzan, V., Bohringer, S., Allaart, C.F., Guchelaar, H.J.
Hepatotoxicity is a serious adverse drug reaction related to methotrexate (MTX). However, the cause of drug-induced liver injury (DILI) is still unclear and unpredictable. Genetic risk factors may predispose for MTX-DILI. Therefore, we conducted a ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10693::26d2fdb55d5643c24635d204fd3184e5
https://hdl.handle.net/1887/3571908
https://hdl.handle.net/1887/3571908
Autor:
Hurkmans, E.G.E., Klumpers, M.J., Dello Russo, C., Witte, W. de, Guchelaar, H.J., Gelderblom, H., Cleton-Jansen, A.M., Vermeulen, S.H., Kaal, S., Graaf, W.T.A. van der, Flucke, U., Gidding, C.E.M., Schreuder, H.W.B., Bont, E.S.J.M. de, Caron, H.N., Gattuso, G., Schiavello, E., Terenziani, M., Massimino, M., McCowage, G., Nagabushan, S., Limaye, A., Rose, V., Catchpoole, D., Jorgensen, A.L., Barton, C., Delaney, L., Hawcutt, D.B., Pirmohamed, M., Pizer, B., Coenen, M.J.H., Loo, D.M.W.M. te
Publikováno v:
Frontiers in Pharmacology, 13
Frontiers in Pharmacology, 13. FRONTIERS MEDIA SA
Frontiers in Pharmacology, 13. FRONTIERS MEDIA SA
Hearing loss (ototoxicity) is a major adverse effect of cisplatin and carboplatin chemotherapy. The aim of this study is to identify novel genetic variants that play a role in platinum-induced ototoxicity. Therefore, a genome-wide association study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ab554ae826822b89d939d18c4802aab
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/290144
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/290144
Publikováno v:
Clinics in Laboratory Medicine, 42(4), 587-602. W B SAUNDERS CO-ELSEVIER INC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::40ab9c11a278c430b582b250d329b05b
https://hdl.handle.net/1887/3593867
https://hdl.handle.net/1887/3593867
Publikováno v:
Pharmacogenomics
Pharmacogenomics, 22(16), 1081-1089. FUTURE MEDICINE LTD
Pharmacogenomics, 22(16), 1081-1089. FUTURE MEDICINE LTD
Genetic variation in the gene encoding CYP2D6 is used to guide drug prescribing in clinical practice. However, genetic variants in CYP2D6 show substrate-specific effects that are currently not accounted for. With a systematic literature, we retrieved
Publikováno v:
Frontiers in Pharmacology, 13. FRONTIERS MEDIA SA
Aim: To provide a comparison of genotyping for HLA risk alleles versus patch testing to determine which of these two tests is a better diagnostic tool for cutaneous hypersensitivity reactions caused by anti-seizure medication.Methods: A literature st
Autor:
ten Brink, M.H., Zwaveling, J., Swen, J.J., Bredius, R.G.M., Lankester, A.C., Guchelaar, H.J.
Publikováno v:
In Drug Discovery Today October 2014 19(10):1572-1586
Autor:
Laar, S.A. van, Gombert-Handoko, K.B., Wassenaar, S., Kroep, J.R., Guchelaar, H.J., Zwaveling, J.
Publikováno v:
Supportive Care in Cancer. SPRINGER
Supportive Care in Cancer
Supportive Care in Cancer
Purpose Chemotherapy-induced febrile neutropenia (FN) is a life-threatening and chemotherapy dose-limiting adverse event. FN can be prevented with granulocyte-colony stimulating factors (G-CSFs). Guidelines recommend primary G-CSF use for patients re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17a1ed5d016bb4b1d587ffa3028ce65
https://hdl.handle.net/1887/3458839
https://hdl.handle.net/1887/3458839